EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 178 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $736,000 | +1.4% | 10,616 | +10.6% | 0.00% | 0.0% |
| Q2 2018 | $726,000 | +72.4% | 9,601 | +20.2% | 0.00% | 0.0% |
| Q1 2018 | $421,000 | +11.1% | 7,990 | +25.6% | 0.00% | 0.0% |
| Q3 2017 | $379,000 | +3.3% | 6,359 | +36.6% | 0.00% | 0.0% |
| Q2 2017 | $367,000 | +13.6% | 4,655 | +19.7% | 0.00% | 0.0% |
| Q1 2017 | $323,000 | +23.3% | 3,889 | +17.6% | 0.00% | 0.0% |
| Q4 2016 | $262,000 | – | 3,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |